Xentria

Chicago, United States

Xentria is a biotech company focused on developing novel therapeutics to address unmet clinical needs.

$25.0M raised

Oct 2022

Undisclosed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Xentria

How much funding has Xentria raised?

Xentria has raised $25.0M in total funding. The most recent round was Undisclosed. The last funding was announced in October 2022.

Where is Xentria headquartered?

Xentria is headquartered in Chicago, United States.

What does Xentria do?

Xentria is a biotech company focused on developing novel therapeutics to address unmet clinical needs.

What stage is Xentria at?

Xentria is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 18, 2022.

MLA

"Xentria — Funding & Investors." VCBacked, October 18, 2022, https://www.vcbacked.co/company/xentria. Accessed July 5, 2026.

APA

VCBacked. (2022). Xentria — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/xentria

Wikipedia (cite web)

{{cite web |title=Xentria — Funding & Investors |url=https://www.vcbacked.co/company/xentria |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 18, 2022.